3.22.2.2 html 91 211 1 false 41 0 false 9 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.rezolutebio.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Unaudited Condensed Consolidated Balance Sheets Sheet http://www.rezolutebio.com/role/StatementUnauditedCondensedConsolidatedBalanceSheets Unaudited Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.rezolutebio.com/role/StatementUnauditedCondensedConsolidatedBalanceSheetsParenthetical Unaudited Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Unaudited Condensed Consolidated Statements of Operations Sheet http://www.rezolutebio.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations Unaudited Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Unaudited Condensed Consolidated Statements of Shareholders' Equity Sheet http://www.rezolutebio.com/role/StatementUnauditedCondensedConsolidatedStatementsOfShareholdersEquity Unaudited Condensed Consolidated Statements of Shareholders' Equity Statements 5 false false R6.htm 00400 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://www.rezolutebio.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows Unaudited Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.rezolutebio.com/role/DisclosureNatureOfOperationsAndSummaryOfSignificantAccountingPolicies NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 10201 - Disclosure - LIQUIDITY Sheet http://www.rezolutebio.com/role/DisclosureLiquidity LIQUIDITY Notes 8 false false R9.htm 10301 - Disclosure - OPERATING LEASES Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeases OPERATING LEASES Notes 9 false false R10.htm 10401 - Disclosure - LICENSE AGREEMENTS Sheet http://www.rezolutebio.com/role/DisclosureLicenseAgreements LICENSE AGREEMENTS Notes 10 false false R11.htm 10501 - Disclosure - EMBEDDED DERIVATIVE LIABILITY Sheet http://www.rezolutebio.com/role/DisclosureEmbeddedDerivativeLiability EMBEDDED DERIVATIVE LIABILITY Notes 11 false false R12.htm 10601 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquity SHAREHOLDERS' EQUITY Notes 12 false false R13.htm 10701 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrants SHARE-BASED COMPENSATION AND WARRANTS Notes 13 false false R14.htm 10801 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.rezolutebio.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 14 false false R15.htm 10901 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.rezolutebio.com/role/DisclosureRelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 15 false false R16.htm 11001 - Disclosure - INCOME TAXES Sheet http://www.rezolutebio.com/role/DisclosureIncomeTaxes INCOME TAXES Notes 16 false false R17.htm 11101 - Disclosure - NET LOSS PER SHARE Sheet http://www.rezolutebio.com/role/DisclosureNetLossPerShare NET LOSS PER SHARE Notes 17 false false R18.htm 11201 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrations FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS Notes 18 false false R19.htm 20102 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.rezolutebio.com/role/DisclosureNatureOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 19 false false R20.htm 30303 - Disclosure - OPERATING LEASES (Tables) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesTables OPERATING LEASES (Tables) Tables http://www.rezolutebio.com/role/DisclosureOperatingLeases 20 false false R21.htm 30703 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS (Tables) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsTables SHARE-BASED COMPENSATION AND WARRANTS (Tables) Tables http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrants 21 false false R22.htm 31103 - Disclosure - NET LOSS PER SHARE (Tables) Sheet http://www.rezolutebio.com/role/DisclosureNetLossPerShareTables NET LOSS PER SHARE (Tables) Tables http://www.rezolutebio.com/role/DisclosureNetLossPerShare 22 false false R23.htm 31203 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables) Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrationsTables FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables) Tables http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrations 23 false false R24.htm 40101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.rezolutebio.com/role/DisclosureNatureOfOperationsAndSummaryOfSignificantAccountingPoliciesDetails NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.rezolutebio.com/role/DisclosureNatureOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies 24 false false R25.htm 40201 - Disclosure - LIQUIDITY (Details) Sheet http://www.rezolutebio.com/role/DisclosureLiquidityDetails LIQUIDITY (Details) Details http://www.rezolutebio.com/role/DisclosureLiquidity 25 false false R26.htm 40301 - Disclosure - OPERATING LEASES (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesDetails OPERATING LEASES (Details) Details http://www.rezolutebio.com/role/DisclosureOperatingLeasesTables 26 false false R27.htm 40302 - Disclosure - OPERATING LEASES - Assets and operating lease liabilities (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesAssetsAndOperatingLeaseLiabilitiesDetails OPERATING LEASES - Assets and operating lease liabilities (Details) Details 27 false false R28.htm 40303 - Disclosure - OPERATING LEASES - Operating lease expense (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesOperatingLeaseExpenseDetails OPERATING LEASES - Operating lease expense (Details) Details 28 false false R29.htm 40304 - Disclosure - OPERATING LEASES - Future Operating Lease Payments (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesFutureOperatingLeasePaymentsDetails OPERATING LEASES - Future Operating Lease Payments (Details) Details 29 false false R30.htm 40305 - Disclosure - OPERATING LEASES - Headquarters Lease (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesHeadquartersLeaseDetails OPERATING LEASES - Headquarters Lease (Details) Details 30 false false R31.htm 40306 - Disclosure - OPERATING LEASES - Future Payments of Lease Yet to Commence (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesFuturePaymentsOfLeaseYetToCommenceDetails OPERATING LEASES - Future Payments of Lease Yet to Commence (Details) Details 31 false false R32.htm 40401 - Disclosure - LICENSE AGREEMENTS (Details) Sheet http://www.rezolutebio.com/role/DisclosureLicenseAgreementsDetails LICENSE AGREEMENTS (Details) Details http://www.rezolutebio.com/role/DisclosureLicenseAgreements 32 false false R33.htm 40501 - Disclosure - EMBEDDED DERIVATIVE LIABILITY (Details) Sheet http://www.rezolutebio.com/role/DisclosureEmbeddedDerivativeLiabilityDetails EMBEDDED DERIVATIVE LIABILITY (Details) Details http://www.rezolutebio.com/role/DisclosureEmbeddedDerivativeLiability 33 false false R34.htm 40601 - Disclosure - SHAREHOLDERS' EQUITY - July 2022 Financing (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquityJuly2022FinancingDetails SHAREHOLDERS' EQUITY - July 2022 Financing (Details) Details 34 false false R35.htm 40602 - Disclosure - SHAREHOLDERS' EQUITY - Equity Distribution Agreement (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquityEquityDistributionAgreementDetails SHAREHOLDERS' EQUITY - Equity Distribution Agreement (Details) Details 35 false false R36.htm 40603 - Disclosure - SHAREHOLDERS' EQUITY - LPC Purchase Agreement (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquityLpcPurchaseAgreementDetails SHAREHOLDERS' EQUITY - LPC Purchase Agreement (Details) Details 36 false false R37.htm 40701 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Stock Option Plans (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsStockOptionPlansDetails SHARE-BASED COMPENSATION AND WARRANTS - Stock Option Plans (Details) Details 37 false false R38.htm 40702 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Stock Options Outstanding (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsStockOptionsOutstandingDetails SHARE-BASED COMPENSATION AND WARRANTS - Stock Options Outstanding (Details) Details 38 false false R39.htm 40703 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Weighted Average Assumptions (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsWeightedAverageAssumptionsDetails SHARE-BASED COMPENSATION AND WARRANTS - Weighted Average Assumptions (Details) Details 39 false false R40.htm 40704 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Share Based Compensation Expense (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsShareBasedCompensationExpenseDetails SHARE-BASED COMPENSATION AND WARRANTS - Share Based Compensation Expense (Details) Details 40 false false R41.htm 40705 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Warrants (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsWarrantsDetails SHARE-BASED COMPENSATION AND WARRANTS - Warrants (Details) Details 41 false false R42.htm 40706 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Additional Information (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsAdditionalInformationDetails SHARE-BASED COMPENSATION AND WARRANTS - Additional Information (Details) Details 42 false false R43.htm 40901 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.rezolutebio.com/role/DisclosureRelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.rezolutebio.com/role/DisclosureRelatedPartyTransactions 43 false false R44.htm 41101 - Disclosure - NET LOSS PER SHARE - Weighted Average Number of Shares Outstanding (Details) Sheet http://www.rezolutebio.com/role/DisclosureNetLossPerShareWeightedAverageNumberOfSharesOutstandingDetails NET LOSS PER SHARE - Weighted Average Number of Shares Outstanding (Details) Details 44 false false R45.htm 41102 - Disclosure - NET LOSS PER SHARE - Anti-dilutive (Details) Sheet http://www.rezolutebio.com/role/DisclosureNetLossPerShareAntiDilutiveDetails NET LOSS PER SHARE - Anti-dilutive (Details) Details 45 false false R46.htm 41201 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Summary of Changes in the Fair Value (Details) Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrationsSummaryOfChangesInFairValueDetails FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Summary of Changes in the Fair Value (Details) Details 46 false false R47.htm 41402 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Additional Information (Details) Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrationsAdditionalInformationDetails FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Additional Information (Details) Details 47 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 14 fact(s) appearing in ix:hidden were eligible for transformation: rzlt:ClassOfWarrantOrRightExpirations, rzlt:ConcentrationRiskNumberOfFinancialInstitutions, rzlt:NumberOfConsecutiveBusinessDaysForSelectingThreeLowestClosingSalePrices, us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1, us-gaap:CommonStockSharesIssued, us-gaap:EarningsPerShareDiluted, us-gaap:OperatingLeaseLiabilityNoncurrent, us-gaap:PreferredStockSharesOutstanding, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - rzlt-20220930x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 3 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies, us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList - rzlt-20220930x10q.htm 9 rzlt-20220930x10q.htm rzlt-20220930.xsd rzlt-20220930_cal.xml rzlt-20220930_def.xml rzlt-20220930_lab.xml rzlt-20220930_pre.xml rzlt-20220930xex31d1.htm rzlt-20220930xex32d1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true